Slovene national guidelines for the prevention of hepatitis B reactivation in patients undergoing immunosuppressive therapy
Abstract
Chronic hepatitis B virus infection as well as the presence of a past viral infection may lead to the reactivation of hepatitis B in patients undergoing immunosuppressive therapy due to some underlying diseases. Prompt introduction of a preemptive treatment or chemoprophylaxis may successfully prevent the viral reactivation. For that reason, screening for hepatitis B virus infection prior to the introduction of immunosuppressive therapy is crucial for the management of hepatitis B reactivation. The pathogenesis, risk factors and clinical course of hepatitis B reactivation in patients undergoing immunosuppressive therapy, as well as antiviral agents and the national guidelines for its prevention are presented.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
